skip to main content
Idioma:
Refinado por: Nome da Publicação: The Journal Of Clinical Endocrinology And Metabolism remover assunto: Type 1 Diabetes remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report
Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report

Landstra, Cyril P ; Andres, Axel ; Chetboun, Mikael ; Conte, Caterina ; Kelly, Yvonne ; Berney, Thierry ; de Koning, Eelco J P ; Piemonti, Lorenzo ; Stock, Peter G ; Pattou, François ; Vantyghem, Marie-Christine ; Bellin, Melena D ; Rickels, Michael R

The Journal of clinical endocrinology and metabolism, 2021-10, Vol.106 (10), p.3049-3059 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
2
Examination of the Igls Criteria for Defining Functional Outcomes of [beta]-cell Replacement Therapy: IPITA Symposium Report
Examination of the Igls Criteria for Defining Functional Outcomes of [beta]-cell Replacement Therapy: IPITA Symposium Report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Examination of the Igls Criteria for Defining Functional Outcomes of [beta]-cell Replacement Therapy: IPITA Symposium Report

Landstra, Cyril P ; Andres, Axel ; Chetboun, Mikael ; Conte, Caterina ; Kelly, Yvonne ; Berney, Thierry ; Koning, Eelco J.P. de ; Piemonti, Lorenzo ; Stock, Peter G ; Pattou, Francois ; Vantyghem, Marie-Christine ; Bellin, Melena D ; Rickels, Michael R

The journal of clinical endocrinology and metabolism, 2021-10, Vol.106 (10), p.3049 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
3
Rapamycin Plus Vildagliptin to Recover [beta]-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial
Rapamycin Plus Vildagliptin to Recover [beta]-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rapamycin Plus Vildagliptin to Recover [beta]-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial

Bolla, Andrea Mario ; Gandolfi, Alessandra ; Borgonovo, Elisa ; Laurenzi, Andrea ; Caretto, Amelia ; Molinari, Chiara ; Catalano, Roberta Sara ; Bianconi, Eleonora ; Monti, Paolo ; Sordi, Valeria ; Pellegrini, Silvia ; Lampasona, Vito ; Costa, Sabrina ; Scavini, Marina ; Bosi, Emanuele ; Piemonti, Lorenzo

The journal of clinical endocrinology and metabolism, 2021-02, Vol.106 (2), p.e507 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.